The HOME Core outcome set for clinical trials of atopic dermatitis
Top Cited Papers
Open Access
- 26 March 2022
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 149 (6) , 1899-1911
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Systemic Immunomodulatory Treatments for Patients With Atopic DermatitisJAMA Dermatology, 2020
- The utility of PROMIS domain measures in dermatologic careArchives of Dermatological Research, 2020
- COSMIN guideline for systematic reviews of patient-reported outcome measuresQuality of Life Research, 2018
- Strategies used for measuring long-term control in atopic dermatitis trials: A systematic reviewJournal of the American Academy of Dermatology, 2016
- Correction: Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010PLOS ONE, 2011
- Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, GermanyBritish Journal of Dermatology, 2010
- The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi studyQuality of Life Research, 2010
- Contradicted and Initially Stronger Effects in Highly Cited Clinical ResearchJAMA, 2005
- The Patient-Oriented Eczema MeasureArchives of Dermatology, 2004
- Measurement of body surface area involvement in atopic eczema: an impossible task?British Journal of Dermatology, 1999